The SymCHro - Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair
SymCHro
Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of this Observational Registry Study is to assess the short- and long-term clinical outcomes following the use of Symbotex™ Composite Mesh in primary and incisional abdominal wall hernia surgeries by open or laparoscopic approach, according to the Instruction for use (IFU).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 25, 2014
CompletedFirst Submitted
Initial submission to the registry
July 21, 2014
CompletedFirst Posted
Study publicly available on registry
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2017
CompletedResults Posted
Study results publicly available
November 1, 2019
CompletedJanuary 14, 2025
December 1, 2024
2.9 years
July 21, 2014
September 4, 2018
December 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Peri-operative and Post-operative Complications
Primary endpoint focuses on complications (including recurrence) occurring during procedure, and in short, mid and long-term (measured at 1 month, 1 year and 2 year follow-up respectively) following ventral hernia repair. All peri-, intra- and post- operative complications
Various (measured at 1 month, 1 Year & 2 Year)
Secondary Outcomes (8)
Pain Assessment Measured With VAS Score
Various ( Baseline Day 0, Day 1, Day 8, Month 1, Month 3, 1 year , 2 year
Quality of Life for Patient
Various ( 1 Month, 1 year and 2 Year follow up)
Patient Satisfaction
Various (1 year and 2 year)
Surgeon Satisfaction (Mesh Handling, Mesh Manipulability, Ease of Use)
Day 0 Baseline
Mesh Handling
Day 0 Baseline
- +3 more secondary outcomes
Study Arms (1)
1 GROUP
Only 1 group not predetermined
Eligibility Criteria
adult patients scheduled for primary and incisional abdominal wall hernia surgeries
You may qualify if:
- The first one hundred consecutive adult patients scheduled for primary and incisional abdominal wall hernia surgery by Club Hernie members surgeons using Symbotex™Composite Mesh ;- All patients regardless of gender ≥ 18 years of age presenting with ventral hernias.
- Patients will be informed by surgeon with a written information notice of the nature of the observational registry study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medtronic - MITGlead
Study Sites (1)
Club Hernie association represented by Dr Gillion, in his capacity as President
Montrouge, 92120, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Djamila Bennat
- Organization
- Medtronic
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-François Gillion
ICMJE
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2014
First Posted
August 1, 2014
Study Start
June 25, 2014
Primary Completion
May 22, 2017
Study Completion
May 22, 2017
Last Updated
January 14, 2025
Results First Posted
November 1, 2019
Record last verified: 2024-12